• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗的水痘免疫力:一项年龄分层的系统评价与荟萃分析

Varicella immunity in Iran: an age-stratified systematic review and meta-analysis.

作者信息

Allami Abbas, Mohammadi Navid

机构信息

Department of Infectious Disease, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.

Department of Community Medicine, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.

出版信息

Iran J Microbiol. 2014 Dec;6(6):372-81.

PMID:25926953
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4411421/
Abstract

OBJECTIVES

To generate synthesized information on the epidemiology of VZV infection, as well as an estimation of prevalence of age-specific antibody in Iranian less than 40.

MATERIAL AND METHODS

After exclusion of irrelevant and overlapping reports, 15 papers were included (from nine major cities). Studies were pooled according to the heterogeneity test results. Random effect model methods were used for meta-analysis where significant heterogeneity was observed (age 1-16years).For other age groups, fixed model were used.

RESULTS

Significant heterogeneity was observed in prevalence rates of all childhood age-groups. The seropositivity prevalence increased steeply from the age of 1-5 to 6-10 [from 21.9% (95% CI; 10.8-33.1) to 42.1 %(95% CI; 33.6-50.6)]. At the age of 11 15, 59.4% (95% CI; 46.1-72.8) of children showed to be infected. The rate of seropositivity was more than 87% in individuals of 40 and older.

CONCLUSION

The varicella seroeprevalence in Iran is in accordance with average tropical and temperate areas. Comparison of conducted studies during 2003 to 2011 didn't show any alteration in VZV seroprovalence in Iran.

摘要

目的

生成关于水痘带状疱疹病毒(VZV)感染流行病学的综合信息,并估计伊朗40岁以下特定年龄抗体的流行率。

材料与方法

排除不相关和重叠的报告后,纳入了15篇论文(来自九个主要城市)。根据异质性检验结果对研究进行合并。对于观察到显著异质性的年龄组(1 - 16岁),采用随机效应模型方法进行荟萃分析。对于其他年龄组,使用固定模型。

结果

在所有儿童年龄组的流行率中观察到显著异质性。血清阳性流行率从1 - 5岁到6 - 10岁急剧上升[从21.9%(95%置信区间;10.8 - 33.1)升至42.1%(95%置信区间;33.6 - 50.6)]。在11 - 15岁时,59.4%(95%置信区间;46.1 - 72.8)的儿童显示受到感染。40岁及以上个体的血清阳性率超过87%。

结论

伊朗水痘血清流行率与热带和温带地区的平均水平一致。2003年至2011年期间进行的研究比较未显示伊朗VZV血清流行率有任何变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eedb/4411421/793b8056adf0/IJM-6-372f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eedb/4411421/32832d869ca7/IJM-6-372f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eedb/4411421/46f28798738c/IJM-6-372f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eedb/4411421/24147315dd28/IJM-6-372f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eedb/4411421/793b8056adf0/IJM-6-372f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eedb/4411421/32832d869ca7/IJM-6-372f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eedb/4411421/46f28798738c/IJM-6-372f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eedb/4411421/24147315dd28/IJM-6-372f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/eedb/4411421/793b8056adf0/IJM-6-372f4.jpg

相似文献

1
Varicella immunity in Iran: an age-stratified systematic review and meta-analysis.伊朗的水痘免疫力:一项年龄分层的系统评价与荟萃分析
Iran J Microbiol. 2014 Dec;6(6):372-81.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
A systematic review and meta-analysis of seroprevalence of varicella zoster virus: A nationwide population-based study.水痘带状疱疹病毒血清流行率的系统评价与荟萃分析:一项基于全国人群的研究。
J Clin Virol. 2017 Feb;87:49-59. doi: 10.1016/j.jcv.2016.12.001. Epub 2016 Dec 6.
4
Prevalence of human visceral leishmaniasis in Iran: A systematic review and meta-analysis.伊朗人体内脏利什曼病的流行情况:系统评价和荟萃分析。
Comp Immunol Microbiol Infect Dis. 2021 Apr;75:101604. doi: 10.1016/j.cimid.2020.101604. Epub 2020 Dec 14.
5
Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany.德国水痘疫苗接种前时代儿童和青少年的水痘-带状疱疹病毒血清流行率
BMC Infect Dis. 2017 May 19;17(1):356. doi: 10.1186/s12879-017-2461-2.
6
Prevalence of hepatitis C infection in Iranian hemodialysis patients: An updated systematic review and meta-analysis.伊朗血液透析患者丙型肝炎感染的患病率:一项更新的系统评价和荟萃分析。
J Res Med Sci. 2017 Nov 28;22:123. doi: 10.4103/jrms.JRMS_223_17. eCollection 2017.
7
Seroprevalence of varicella-zoster virus in the German population.德国人群中水痘-带状疱疹病毒的血清流行率。
Vaccine. 2001 Oct 12;20(1-2):121-4. doi: 10.1016/s0264-410x(01)00276-6.
8
Seroprevalence of Toxoplasma gondii in the Iranian pregnant women: A systematic review and meta-analysis.伊朗孕妇弓形虫血清阳性率:一项系统评价与荟萃分析。
Acta Trop. 2016 Jun;158:160-169. doi: 10.1016/j.actatropica.2016.03.003. Epub 2016 Mar 4.
9
Geographic heterogeneity in the association of varicella-zoster virus seropositivity and multiple sclerosis: A systematic review and meta-analysis.水痘带状疱疹病毒血清阳性与多发性硬化症相关性的地理异质性:系统评价和荟萃分析。
Mult Scler Relat Disord. 2021 Aug;53:103024. doi: 10.1016/j.msard.2021.103024. Epub 2021 May 24.
10
Seroepidemiology of Varicella and value of self-reported history of Varicella infection in Iranian medical students.伊朗医科学生水痘的血清流行病学及水痘感染自我报告史的价值
Int J Occup Med Environ Health. 2014 Apr;27(2):304-13. doi: 10.2478/s13382-014-0265-9. Epub 2014 Apr 9.

引用本文的文献

1
Varicella-zoster virus seroprevalence among reproductive-age women in Iran: a meta-analysis and implications for targeted immunization.伊朗育龄妇女中水痘-带状疱疹病毒血清流行率:一项荟萃分析及对靶向免疫的启示
BMC Infect Dis. 2025 Aug 18;25(1):1029. doi: 10.1186/s12879-025-11415-2.
2
Varicella challenges: A case of respiratory tract complications in an elderly patient.水痘引发的挑战:一例老年患者的呼吸道并发症病例
Narra J. 2024 Dec;4(3):e1150. doi: 10.52225/narra.v4i3.1150. Epub 2024 Nov 1.
3
Seroprevalence of VZV and HSV-2 Antibodies among Women of Childbearing Age Referring to Health Centres of Mashhad, Iran: The Need for Consideration of VZV Vaccination Program.

本文引用的文献

1
Seroprevalence of varicella-zoster virus among pregnant women in two teaching hospitals, Tehran, Iran.伊朗德黑兰两家教学医院孕妇中水痘-带状疱疹病毒血清流行率
Iran J Microbiol. 2014 Feb;6(1):37-40.
2
Seroepidemiology of Varicella and value of self-reported history of Varicella infection in Iranian medical students.伊朗医科学生水痘的血清流行病学及水痘感染自我报告史的价值
Int J Occup Med Environ Health. 2014 Apr;27(2):304-13. doi: 10.2478/s13382-014-0265-9. Epub 2014 Apr 9.
3
Seroprevalence of antibodies against varicella-zoster virus among prevalent hemodialysis patients.
伊朗马什哈德健康中心育龄妇女中水痘带状疱疹病毒(VZV)和单纯疱疹病毒2型(HSV-2)抗体的血清流行率:水痘带状疱疹病毒疫苗接种计划的必要性。
Int J Prev Med. 2023 Nov 2;14:123. doi: 10.4103/ijpvm.ijpvm_239_22. eCollection 2023.
4
Varicella infection in the Middle East: Prevalence, complications, and vaccination.中东地区的水痘感染:患病率、并发症及疫苗接种情况
J Res Med Sci. 2018 Apr 26;23:19. doi: 10.4103/jrms.JRMS_979_17. eCollection 2018.
5
Cost-effectiveness of Varicella Vaccination Program in Iran.伊朗水痘疫苗接种计划的成本效益
Int J Prev Med. 2017 Dec 5;8:103. doi: 10.4103/ijpvm.IJPVM_295_16. eCollection 2017.
6
Safety and immunogenicity of Bio Pox™, a live varicella vaccine (Oka strain) in Indian children: A comparative multicentric, randomized phase II/III clinical trial.印度儿童中生物痘苗™(Oka 株)活水痘疫苗的安全性和免疫原性:一项比较性、多中心、随机、Ⅱ/Ⅲ 期临床试验。
Hum Vaccin Immunother. 2017 Sep 2;13(9):2032-2037. doi: 10.1080/21645515.2017.1318236. Epub 2017 May 16.
7
Seroprevalence and Risk Factors of Varicella Zoster Infection in Iranian Adolescents: A Multilevel Analysis; The CASPIAN-III Study.伊朗青少年水痘带状疱疹感染的血清流行率及危险因素:一项多层次分析;CASPIAN-III研究
PLoS One. 2016 Jun 29;11(6):e0158398. doi: 10.1371/journal.pone.0158398. eCollection 2016.
现患血液透析患者中抗水痘-带状疱疹病毒抗体的血清流行率。
Iran J Kidney Dis. 2013 Nov;7(6):475-8.
4
Seroepidemiology of varicella zoster virus in healthcare workers in Babol, Northern Iran.伊朗北部巴博勒医护人员水痘带状疱疹病毒血清流行病学研究
Caspian J Intern Med. 2013 Summer;4(3):686-91.
5
Immunity against varicella zoster virus based on history of previous chickenpox: a study in premarital Iranian women.基于既往水痘病史的水痘带状疱疹病毒免疫力:一项针对伊朗婚前女性的研究。
Int J Infect Dis. 2013 Jul;17(7):e568-9. doi: 10.1016/j.ijid.2013.01.033. Epub 2013 Apr 9.
6
Seroprevalence of varicella-zoster virus in the prevaccine era: a population-based study in Izmir, Turkey.疫苗时代前水痘-带状疱疹病毒的血清流行率:土耳其伊兹密尔的一项基于人群的研究。
J Infect Public Health. 2013 Apr;6(2):115-9. doi: 10.1016/j.jiph.2012.10.003. Epub 2013 Jan 1.
7
National Immunization Program in Iran: whys and why nots.伊朗国家免疫计划:原因及阻力。
Hum Vaccin Immunother. 2013 Jan;9(1):112-4. doi: 10.4161/hv.22521.
8
Seroprevalence of varicella-zoster virus infection in children from Cochabamba: tropical or temperate pattern?科恰班巴儿童水痘-带状疱疹病毒感染的血清流行率:热带模式还是温带模式?
Trop Med Int Health. 2013 Mar;18(3):296-302. doi: 10.1111/tmi.12040. Epub 2012 Dec 20.
9
Seroepidemiology of Varicella Zoster Virus among children, adolescents and medical students in a referral children medical center, Tehran, Iran.伊朗德黑兰一家儿童转诊医疗中心儿童、青少年及医学生中水痘带状疱疹病毒的血清流行病学研究
Iran J Microbiol. 2012 Sep;4(3):136-8.
10
Meta-analyses and Forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis.使用微软Excel电子表格进行Meta分析和森林图绘制:聚焦描述性数据分析的分步指南
BMC Res Notes. 2012 Jan 20;5:52. doi: 10.1186/1756-0500-5-52.